Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 3.302.231.411.201.52

What is the latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS is 3.30 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20253.30
Mar20242.23
Mar20231.41
Mar20221.20
Mar20211.52

How is EV/Net Sales of GLENMARK PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 3.3
47.98
Mar2024 2.23
58.16
Mar2023 1.41
17.50
Mar2022 1.2
-21.05
Mar2021 1.52 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,841.3 Cr -3.4% -2.4% 32.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,905.0 Cr -5.2% -7.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹159,357.0 Cr -5.6% -7.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,788.0 Cr -0.6% 4.8% 25% Stock Analytics
CIPLA ₹110,628.0 Cr -4.5% -9.7% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,441.5 Cr -2.6% -9.7% -10.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.4%

-2.4%

32.4%

SENSEX

-2.1%

-3%

6.8%


You may also like the below Video Courses